FDA.reportPublic FDA data

omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution

RxCUI
2612702
RxNorm name
omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution
Display name
omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution
Full name
omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OmlontiOMIDENEPAG ISOPROPYLOcuvex Therapeutics, Inc.4258e437-7e92-4b09-baf1-01cb158cfc052025-04-21Warnings, Adverse reactionsExact identifier
rxcui: 2612702

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4258e437-7e92-4b09-baf1-01cb158cfc05omidenepag isopropyl 0.002 % Ophthalmic Solution [PSN] · omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [SCD] · omidenepag isopropyl 0.002 % Ophthalmic Solution [SY]33These highlights do not include all the information needed to use OMLONTI ® safely and effectively. See full prescribing information for OMLONTI ® . OMLONTI ® (omidenepag isopropyl ophthalmic solution) 0.002%, for topical ophthalmic use Initial U.S. Approval: 202220250421